Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eos Energy Enterprises Inc (EOSE) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance

Eos Energy Enterprises IncTrade
Iovance Biotherapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Eos Energy Enterprises Inc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Eos Energy Enterprises Inc trades at $2.68 (market cap $1.01B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.86 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 6× Eos Energy Enterprises Inc's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Eos Energy Enterprises Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Eos Energy Enterprises Inc for 16 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.

EOSEIOVA
Market Cap
$1.01B$6.04B
Volume
39,626,54114,805,993
Sector
IndustrialsHealth
52-Week High
$19.19$14.82
52-Week Low
$2.77$1.81
Typical Hold Time
16 Days0 Days
Enterprise Value
$1.34B$5.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eos Energy Enterprises Inc

Eos Energy Enterprises (EOSE) trades at $3.10, down 4.91% today, amid a bearish technical signal. The company is in a high-growth phase, with revenue surging from $114 million in 2025 to $214 million in 2026, but it remains deeply unprofitable, with a net income margin of -246.76% in 2026. Recent positive developments include a major partnership with Google for a $350 million West Virginia project and an $87 million Department of Energy loan advance to expand manufacturing capacity.

The outlook is a high-risk, high-reward proposition. Significant revenue growth and strategic partnerships offer substantial upside potential, with a consensus price target of $7.10. However, persistent negative cash flow from operations, high debt-to-asset ratio of 91.87%, and intense competition in the energy storage sector pose severe risks to shareholder value.

Iovance Biotherapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EOSE
17% Buy83% Sell
Avg holding period · 16 Days
IOVA
100% Buy0% Sell
Avg holding period · 0 Days

About Eos Energy Enterprises Inc

Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.

Read more on EOSE →

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →